You are here

earnings

Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown

Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown

Medtech Dive

Flag link:

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit

Fierce Pharma

Teva Pharmaceutical

Flag link:

Illumina cuts annual profit forecast for second straight quarter

Illumina cuts annual profit forecast for second straight quarter

Yahoo/Reuters

Flag link:

AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug

AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug

Fierce Biotech

sickle cell disease

Flag link:

Novavax posts higher-than-expected revenue, says prepared to further cut costs

Novavax posts higher-than-expected revenue, says prepared to further cut costs

Reuters

Flag link:

Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans

Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans

Investors Business Daily

Teva Pharmaceutical

Flag link:

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches

As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches

Fierce Pharma

Chris Viehbacher

Flag link:

Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat

Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat

Investors Business Daily

Gilead Sciences

Flag link:

Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut

Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut

Reuters

Alzheimer's disease

Flag link:

Axsome expands sales force to support launch of fast-growing depression med Auvelity

Axsome expands sales force to support launch of fast-growing depression med Auvelity

Fierce Pharma

Axesome Therapeutics

Flag link:

BioNTech Stock Jumps On Surprise Profit, Sales Beat

BioNTech Stock Jumps On Surprise Profit, Sales Beat

Investors Business Daily

Flag link:

There's a Silver Lining in Pfizer's Dark Cloud

There's a Silver Lining in Pfizer's Dark Cloud

Motley Fool

Flag link:

Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist

Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist

Reuters

Flag link:

Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink

Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink

Fierce Pharma

Moderna Therapeutics

Flag link:

Novo Nordisk shrugs off supply issues with record sales

Novo Nordisk shrugs off supply issues with record sales

Pharmaphorum

Flag link:

Regeneron beats quarterly profit estimates on eczema treatment strength

Regeneron beats quarterly profit estimates on eczema treatment strength

Reuters

Flag link:

GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales

GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales

BioSpace

Flag link:

A continuing decline in sales of COVID-19 products clips revenue at Pfizer

A continuing decline in sales of COVID-19 products clips revenue at Pfizer

Yahoo Finance

Flag link:

Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings

Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings

Fierce Biotech

Flag link:

4 medtech companies to watch this week in earnings

4 medtech companies to watch this week in earnings

Medtech Dive

Flag link:

Pages